Immunoscape
1 known investors
ImmunoScape is developing a combination cancer therapy based on a "seed-and-boost" approach designed to deliver anti-tumor efficacy at lower cost. The company operates in oncology and immunotherapy.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Immunoscape do?
- ImmunoScape is developing a combination cancer therapy based on a "seed-and-boost" approach designed to deliver anti-tumor efficacy at lower cost. The company operates in oncology and immunotherapy.
- Who are Immunoscape's investors?
- Immunoscape's investors include Anzu Partners.